Hot sale cancer marker PGI monoclonal antibody

• Customization: Available
• Type: Ivd Reagent Raw Materials
• Storage: 2-10ºC
• Model NO.: antibody
• Shelf Life: 2 Years
• Purity: 96%
• Delivery Time: 7-10 Days
• Application Platform: Elisa, Fla, Tubidity and Colloidal Gold
• Usage: Reagent Kits, Research
• Appearance: Liquid
• Transport Package: Bottle
• Specification: 1mg/bottle
• Trademark: Aoke Botai
• Origin: China
• HS Code: 3002130000
• Production Capacity: 500g/Year

Product Description

Free sample best pairs PGI mAb antibody antigen
As an original manufacturer of antibody and antigen for IND products, we produce and supply in bulk below antibodies for ifectous disease testsuitable for ELISA,CLIA, FIA,rapid test
Product information

As an original manufacturer of and antigen for IVD products, we produce and supply in bulk below monoclonal antibodies for tumor marker test , suitable for ELISA, CLIA, FIA, rapid test:

AFP, CEA, PSA, CA125, CA199, Ferritin, HE4, PGI, PGII, S100β, NSE a1-MG, PIVKA II, SCCA, NNE, VEGF, HER2, ProGRP 
Purity: >95%

Storage: cool or freezer as per COA instruction

Period of validity: as per COA instruction

Transportation: with cool pack

Catalogue No.	Clone No.	Recommendation (detector-capture)
A6101	4D10	FIA: 13D4-6B12 9H12-5D8 14E3-4D10   LEITA: 4D10-9H12/13D4   ELISA: 4D10-6B12
A6103	13D4
A6104	6B12
A6105	9H12
A6106	5D8
A6109	14E3
A6110	12E10
A6210	4C11

Hot sale products 
Introduction of manufacturer

Wuhan Aoke Botai Biotechnology Co., Ltd., formerly founded in 2002, is a high-tech company specializing in the R & D, production and sales of in vitro diagnostic raw materials (including antigens and antibodies). At the same time, it is a high-tech company that provides customized services for all kinds of monoclonal antibodies, multi-antibodies and recombinant proteins. After decades of development, Our company has passed 15013485 and 1509001 certification, and has won honors such as Optical Valley Gazelle, 3551 talents, provincial innovative small and medium-sized enterprises and provincial "specialized special new" small and medium-sized enterprises. After years of painstaking research and development, the company has created two major technology platforms that are widely praised in the industry, namely, mouse monoclonal antibody hybrid pain platform and recombinant protein expression platform. The mouse hybridoma platform is a leader in the industry, and we are the first company in China to use a pair of monoclonal antibodies to detect hepatitis B HBeAg. The recombinant protein platforms are E. coli expression platform, Pichia pastoris expression platform, insect cell-baculovirus expression system and mammalian cell expression platform. At the same time, the company also has 8000 square meters of animal feeding base, which can fully meet the supply needs of diagnostic reagent manufacturers.

 

Our teams
 

Our certification

Wuhan Aoke Botai Biotechnology Co.,ltd